Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析

◆英語タイトル:Auris Medical Holding Ltd (EARS) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH134156FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:バミューダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Auris Medical Holding Ltd (EARS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Auris Medical Holding Ltd (Auris Medical) is a clinical-stage biopharmaceutical company with focus on neurotology and CNS disorders. The company’s pipeline product candidates are in various clinical phases intended for the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, Vertigo, sudden loss of hearing, antipsychotic-induced weight gain and somnolence. It has research collaboration and licensing agreements with research institutions such as King’s College London, Pharmaceutical and Biotechnology companies including Xigen and Inserm. Auris Medical is headquartered in Hamilton, Bermuda.

Auris Medical Holding Ltd Key Recent Developments

Sep 17,2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16,2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30,2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04,2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15,2019: Auris Medical provides business update and reports first half 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Auris Medical Holding Ltd – Key Facts
Auris Medical Holding Ltd – Key Employees
Auris Medical Holding Ltd – Key Employee Biographies
Auris Medical Holding Ltd – Major Products and Services
Auris Medical Holding Ltd – History
Auris Medical Holding Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Auris Medical Holding Ltd – Business Description
R&D Overview
Auris Medical Holding Ltd – Corporate Strategy
Auris Medical Holding Ltd – SWOT Analysis
SWOT Analysis – Overview
Auris Medical Holding Ltd – Strengths
Auris Medical Holding Ltd – Weaknesses
Auris Medical Holding Ltd – Opportunities
Auris Medical Holding Ltd – Threats
Auris Medical Holding Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 17, 2020: Auris Medical provides business update and reports first half 2020 financial results
Apr 16, 2020: Auris Medical provides business update and reports second half and full year 2019 financial results
Dec 30, 2019: Auris Medical announces formation of new subsidiary for development projects in tinnitus and hearing loss
Sep 04, 2019: Auris Medical announces appointment of new Chief Financial Officer
Aug 15, 2019: Auris Medical provides business update and reports first half 2019 financial results
May 23, 2019: Auris Medical Holding provides corporate update
Mar 14, 2019: Auris Medical provides business update and reports fourth quarter and full year 2018 financial results
Feb 01, 2019: Auris Medical announces full repayment of Hercules loan facility
Jan 29, 2019: Auris Medical to Redomicile Holding Company from Switzerland to Bermuda
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Auris Medical Holding Ltd, Key Facts
Auris Medical Holding Ltd, Key Employees
Auris Medical Holding Ltd, Key Employee Biographies
Auris Medical Holding Ltd, Major Products and Services
Auris Medical Holding Ltd, History
Auris Medical Holding Ltd, Subsidiaries
Auris Medical Holding Ltd, Key Competitors
Auris Medical Holding Ltd, Ratios based on current share price
Auris Medical Holding Ltd, Annual Ratios
Auris Medical Holding Ltd, Annual Ratios (Cont...1)
Auris Medical Holding Ltd, Interim Ratios
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Auris Medical Holding Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Auris Medical Holding Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Auris Medical Holding Ltd (EARS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biocad:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocad is a biotechnology company that conducts research and development services. The company develops, manufactures and distributes generic pharmaceutical products. It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases t …
  • Parexel International Corp:企業の戦略的SWOT分析
    Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Jack Chia Industries (Thailand) Public Company Ltd (JCT):企業の財務・戦略的SWOT分析
    Jack Chia Industries (Thailand) Public Company Ltd (JCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • Latecoere S.A.:企業の戦略・SWOT・財務情報
    Latecoere S.A. - Strategy, SWOT and Corporate Finance Report Summary Latecoere S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alcoa Corp:企業の戦略・SWOT・財務情報
    Alcoa Corp - Strategy, SWOT and Corporate Finance Report Summary Alcoa Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Chr. Hansen Holding A/S
    Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report Summary Chr. Hansen Holding A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ultra Clean Holdings Inc (UCTT):企業の財務・戦略的SWOT分析
    Summary Ultra Clean Holdings Inc (UCH) is a developer and supplier of critical systems and subsystems. The company’s products include precision robotic solutions, gas delivery systems, industrial and automation production equipment, chemical delivery modules, top-plate assemblies, wafer cleaning sub …
  • Carmat SAS (ALCAR):企業の財務・戦略的SWOT分析
    Summary Carmat SAS (Carmat) is a medical equipment company that provides artificial organs. The company provides development of innovative artificial organs, artificial heart and other vital organs, among others. Carmat artificial heart products consist of an implantable heart. The company offers co …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Thames Water Utilities Ltd:企業の戦略・SWOT・財務情報
    Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report Summary Thames Water Utilities Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Electrovaya Inc (EFL):企業の財務・戦略的SWOT分析
    Electrovaya Inc (EFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Azomures SA:企業の戦略的SWOT分析
    Azomures SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Amgen Inc (AMGN):企業の財務・戦略的SWOT分析
    Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Celsion Corp (CLSN):医療機器:M&Aディール及び事業提携情報
    Summary Celsion Corp (Celsion) is an oncology company that strives to develop a portfolio of new cancer treatments, including directed chemotherapies, RNA or DNA based therapies and immunotherapies. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), T …
  • Big 5 Sporting Goods Corp:企業の戦略・SWOT・財務分析
    Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report Summary Big 5 Sporting Goods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Axikin Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Axikin Pharmaceuticals Inc (Axikin) is a biopharmaceutical company that develops small molecule therapeutics for respiratory disorders. The company offers pre-clinical and research programs with small molecule therapeutics for applications in asthma, chronic obstructive pulmonary disease, in …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆